Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Carcinoma and ABCC2[original query] |
|---|
| Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. British journal of clinical pharmacology 2005 Apr 59 (4): 415-24. Zhou Qingyu, Sparreboom Alex, Tan Eng-Huat, Cheung Yin-Bun, Lee Ann, Poon Donald, Lee Edmund J D, Chowbay Balr |
| Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer. Digestion 2009 80 (1): 36-9. Hoblinger A, Grunhage F, Sauerbruch T, Lammert |
| The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients. Cancer chemotherapy and pharmacology 2011 Jun 67 (6): 1471-8. Chew Sin-Chi, Singh Onkar, Chen Xiangai, Ramasamy Rathi Devi, Kulkarni Tejal, Lee Edmund J D, Tan Eng-Huat, Lim Wan-Teck, Chowbay Balr |
| A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis. International journal of cancer. Journal international du cancer 2012 Dec 131 (12): 2920-8. Campa Daniele, Müller Phillip, Edler Lutz, Knoefel Lena, Barale Roberto, Heussel Claus P, Thomas Michael, Canzian Federico, Risch Ange |
| Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma. Anti-cancer drugs 2012 Dec . Tsuchiya N, Narita S, Inoue T, Hasunuma N, Numakura K, Horikawa Y, Satoh S, Notoya T, Fujishima N, Hatakeyama S, Ohyama C, Habuchi T |
| The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer. Oral oncology 2019 Sep 98 48-52. De Marchi Pedro, Melendez Matias E, Laus Ana C, Kuhlmann Pamela A, de Carvalho Ana Carolina, Arantes Lidia Maria R B, Evangelista Adriane F, Andrade Edilene S, de Castro Gilberto, Reis Rui M, Carvalho André Lopes, de Souza Viana Lucia |
| Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients. Oral oncology 2019 Feb 89 72-78. Teft Wendy A, Winquist Eric, Nichols Anthony C, Kuruvilla Sara, Richter Suzanne, Parker Christina, Francis Peggy, Trinnear Maureen, Lukovic Jelena, Bukhari Nedal, Choi Yun-Hee, Welch Stephen, Palma David A, Yoo John, Kim Richard |
| Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma. Future oncology (London, England) 2021 3 17 (18): 2351-2363. Yang Ying, Jia Jun, Sun Zhiwei, Liu Chuanling, Li Ziwei, Xiao Yanjie, Yu Jing, Du Feng, Shi Youwu, Sun Jing, Shui Jing, Zhang Xiaodo |
| Clinical Impact of X-Ray Repair Cross-Complementary 1 (XRCC1) and the Immune Environment in Colorectal Adenoma-Carcinoma Pathway Progression. Journal of inflammation research 2021 11 14 5403-5417. Zhang Yu, Zhang Xin, Jin Zhuoyi, Chen Huiyan, Zhang Chenjing, Wang Wangyue, Jing Jiyong, Pan Wenshe |
| Association between polymorphisms of ABCB1 and prognosis in esophageal squamous cell carcinoma patients treated with taxane. The journal of gene medicine 2022 Jun e3434. Sun Zhiwei, Yang Xin, Du Feng, Shi Youwu, Sun Jing, Jia Jun, Liu Chuanling, Xiao Yanjie, Yu Jing, Zhang Xiaodong, Yang Yi |
| Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy. The journal of gene medicine 2022 10 25 (1): e3460. Sharma Parul, Singh Navneet, Sharma Siddhar |
| Genetic issues in ICP. Obstetric medicine 2024 9 17 (3): 157-161. Julia Zöllner, Catherine Williamson, Peter H Dix |
- Page last reviewed:Feb 1, 2024
- Content source: